Logo image of EXPE

EXPEDIA GROUP INC (EXPE) Stock Fundamental Analysis

NASDAQ:EXPE - Nasdaq - US30212P3038 - Common Stock - Currency: USD

171.77  +2.66 (+1.57%)

After market: 171.77 0 (0%)

Fundamental Rating

5

EXPE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 134 industry peers in the Hotels, Restaurants & Leisure industry. EXPE scores excellent on profitability, but there are concerns on its financial health. EXPE is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year EXPE was profitable.
In the past year EXPE had a positive cash flow from operations.
In multiple years EXPE reported negative net income over the last 5 years.
EXPE had a positive operating cash flow in 4 of the past 5 years.
EXPE Yearly Net Income VS EBIT VS OCF VS FCFEXPE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B -4B

1.2 Ratios

With a decent Return On Assets value of 4.53%, EXPE is doing good in the industry, outperforming 66.41% of the companies in the same industry.
The Return On Equity of EXPE (80.26%) is better than 98.47% of its industry peers.
The Return On Invested Capital of EXPE (11.64%) is better than 77.10% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EXPE is below the industry average of 10.55%.
The last Return On Invested Capital (11.64%) for EXPE is above the 3 year average (6.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.53%
ROE 80.26%
ROIC 11.64%
ROA(3y)1.36%
ROA(5y)-1.53%
ROE(3y)18.1%
ROE(5y)-7.52%
ROIC(3y)6.14%
ROIC(5y)N/A
EXPE Yearly ROA, ROE, ROICEXPE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

1.3 Margins

Looking at the Profit Margin, with a value of 7.92%, EXPE is in the better half of the industry, outperforming 67.18% of the companies in the same industry.
In the last couple of years the Profit Margin of EXPE has grown nicely.
The Operating Margin of EXPE (11.41%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of EXPE has grown nicely.
EXPE has a Gross Margin of 89.17%. This is amongst the best in the industry. EXPE outperforms 99.24% of its industry peers.
EXPE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.41%
PM (TTM) 7.92%
GM 89.17%
OM growth 3YN/A
OM growth 5Y10.37%
PM growth 3YN/A
PM growth 5Y11.4%
GM growth 3Y9.04%
GM growth 5Y1.24%
EXPE Yearly Profit, Operating, Gross MarginsEXPE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

EXPE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, EXPE has less shares outstanding
The number of shares outstanding for EXPE has been reduced compared to 5 years ago.
The debt/assets ratio for EXPE has remained at the same level compared to a year ago.
EXPE Yearly Shares OutstandingEXPE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
EXPE Yearly Total Debt VS Total AssetsEXPE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 1.19, we must say that EXPE is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of EXPE (1.19) is worse than 61.07% of its industry peers.
EXPE has a debt to FCF ratio of 3.28. This is a good value and a sign of high solvency as EXPE would need 3.28 years to pay back of all of its debts.
EXPE has a better Debt to FCF ratio (3.28) than 79.39% of its industry peers.
EXPE has a Debt/Equity ratio of 3.95. This is a high value indicating a heavy dependency on external financing.
EXPE's Debt to Equity ratio of 3.95 is in line compared to the rest of the industry. EXPE outperforms 43.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.95
Debt/FCF 3.28
Altman-Z 1.19
ROIC/WACC1.52
WACC7.68%
EXPE Yearly LT Debt VS Equity VS FCFEXPE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B 4B -4B 6B 8B

2.3 Liquidity

A Current Ratio of 0.73 indicates that EXPE may have some problems paying its short term obligations.
EXPE has a worse Current ratio (0.73) than 62.60% of its industry peers.
EXPE has a Quick Ratio of 0.73. This is a bad value and indicates that EXPE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.73, EXPE is in line with its industry, outperforming 42.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.73
EXPE Yearly Current Assets VS Current LiabilitesEXPE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.61% over the past year.
EXPE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.07% yearly.
EXPE shows a small growth in Revenue. In the last year, the Revenue has grown by 6.56%.
Measured over the past years, EXPE shows a small growth in Revenue. The Revenue has been growing by 2.73% on average per year.
EPS 1Y (TTM)23.61%
EPS 3YN/A
EPS 5Y11.07%
EPS Q2Q%13.31%
Revenue 1Y (TTM)6.56%
Revenue growth 3Y35.17%
Revenue growth 5Y2.73%
Sales Q2Q%3.33%

3.2 Future

The Earnings Per Share is expected to grow by 14.71% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.51% on average over the next years.
EPS Next Y22.39%
EPS Next 2Y20.97%
EPS Next 3Y20.88%
EPS Next 5Y14.71%
Revenue Next Year5.81%
Revenue Next 2Y6.86%
Revenue Next 3Y6.9%
Revenue Next 5Y6.51%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXPE Yearly Revenue VS EstimatesEXPE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
EXPE Yearly EPS VS EstimatesEXPE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.85, the valuation of EXPE can be described as correct.
Based on the Price/Earnings ratio, EXPE is valued cheaply inside the industry as 84.73% of the companies are valued more expensively.
EXPE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.42.
A Price/Forward Earnings ratio of 11.95 indicates a reasonable valuation of EXPE.
Based on the Price/Forward Earnings ratio, EXPE is valued cheaply inside the industry as 89.31% of the companies are valued more expensively.
EXPE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.39.
Industry RankSector Rank
PE 14.85
Fwd PE 11.95
EXPE Price Earnings VS Forward Price EarningsEXPE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EXPE is valued a bit cheaper than the industry average as 71.76% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, EXPE is valued cheaply inside the industry as 92.37% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.56
EV/EBITDA 9.68
EXPE Per share dataEXPE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

EXPE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXPE has a very decent profitability rating, which may justify a higher PE ratio.
EXPE's earnings are expected to grow with 20.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.66
PEG (5Y)1.34
EPS Next 2Y20.97%
EPS Next 3Y20.88%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EXPE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EXPEDIA GROUP INC

NASDAQ:EXPE (1/28/2025, 8:00:02 PM)

After market: 171.77 0 (0%)

171.77

+2.66 (+1.57%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-06 2025-02-06/amc
Inst Owners98.77%
Inst Owner Change-0.68%
Ins Owners0.49%
Ins Owner Change-0.17%
Market Cap22.05B
Analysts71.36
Price Target190 (10.61%)
Short Float %4.59%
Short Ratio3.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.75%
Min EPS beat(2)-0.95%
Max EPS beat(2)12.45%
EPS beat(4)3
Avg EPS beat(4)49.72%
Min EPS beat(4)-0.95%
Max EPS beat(4)187.08%
EPS beat(8)5
Avg EPS beat(8)-22.96%
EPS beat(12)8
Avg EPS beat(12)-7.24%
EPS beat(16)10
Avg EPS beat(16)-4.01%
Revenue beat(2)0
Avg Revenue beat(2)-2.26%
Min Revenue beat(2)-3.22%
Max Revenue beat(2)-1.3%
Revenue beat(4)1
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)0.87%
Revenue beat(8)1
Avg Revenue beat(8)-1.79%
Revenue beat(12)2
Avg Revenue beat(12)-1.28%
Revenue beat(16)5
Avg Revenue beat(16)-0.92%
PT rev (1m)0.94%
PT rev (3m)22.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.94%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.52%
Valuation
Industry RankSector Rank
PE 14.85
Fwd PE 11.95
P/S 1.65
P/FCF 11.56
P/OCF 8.32
P/B 16.68
P/tB N/A
EV/EBITDA 9.68
EPS(TTM)11.57
EY6.74%
EPS(NY)14.37
Fwd EY8.37%
FCF(TTM)14.86
FCFY8.65%
OCF(TTM)20.64
OCFY12.02%
SpS104.36
BVpS10.3
TBVpS-50.46
PEG (NY)0.66
PEG (5Y)1.34
Profitability
Industry RankSector Rank
ROA 4.53%
ROE 80.26%
ROCE 17.73%
ROIC 11.64%
ROICexc 27.12%
ROICexgc N/A
OM 11.41%
PM (TTM) 7.92%
GM 89.17%
FCFM 14.24%
ROA(3y)1.36%
ROA(5y)-1.53%
ROE(3y)18.1%
ROE(5y)-7.52%
ROIC(3y)6.14%
ROIC(5y)N/A
ROICexc(3y)10.39%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.36%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y20.18%
OM growth 3YN/A
OM growth 5Y10.37%
PM growth 3YN/A
PM growth 5Y11.4%
GM growth 3Y9.04%
GM growth 5Y1.24%
F-Score8
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 3.95
Debt/FCF 3.28
Debt/EBITDA 2.21
Cap/Depr 88.97%
Cap/Sales 5.54%
Interest Coverage 6.61
Cash Conversion 112.15%
Profit Quality 179.74%
Current Ratio 0.73
Quick Ratio 0.73
Altman-Z 1.19
F-Score8
WACC7.68%
ROIC/WACC1.52
Cap/Depr(3y)90.37%
Cap/Depr(5y)94.64%
Cap/Sales(3y)6.7%
Cap/Sales(5y)9.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.61%
EPS 3YN/A
EPS 5Y11.07%
EPS Q2Q%13.31%
EPS Next Y22.39%
EPS Next 2Y20.97%
EPS Next 3Y20.88%
EPS Next 5Y14.71%
Revenue 1Y (TTM)6.56%
Revenue growth 3Y35.17%
Revenue growth 5Y2.73%
Sales Q2Q%3.33%
Revenue Next Year5.81%
Revenue Next 2Y6.86%
Revenue Next 3Y6.9%
Revenue Next 5Y6.51%
EBIT growth 1Y11.13%
EBIT growth 3YN/A
EBIT growth 5Y13.38%
EBIT Next Year129.66%
EBIT Next 3Y40.88%
EBIT Next 5Y26.47%
FCF growth 1Y-41.84%
FCF growth 3YN/A
FCF growth 5Y10.95%
OCF growth 1Y-32.2%
OCF growth 3YN/A
OCF growth 5Y6.37%